BioSpace News Archive

NI Research is pleased to announce that the September/October issue of NeuroPerspective has been released. It features our comprehensive annual review of the Alzheimer’s space, including an assessment of the current conceptual trends vis-a-vis pathophysiology and therapeutic targets.

Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced the promotion of Bill Steinkrauss to Chief Financial Officer

Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, and hc1, the bioinformatics leader in precision testing, today unveiled Quest® Lab Stewardship™ powered by hc1®, an innovative new service that employs machine learning to harmonize laboratory testing across health systems in order to help optimize laboratory test utilization.*

Meitheal Pharmaceuticals (“Meitheal”), a fully integrated generic injectables company today announced the launch of the Company’s eight presentations of heparin sodium injection, USP in the United States (US).

Contraceptive App Natural Cycles and UCL release new study revealing that, contrary to popular belief, menstrual cycles are considerably varied with only 13% of women having cycles that last 28 days.

Aytu BioScience, Inc. (NASDAQ: AYTU), and Innovus Pharmaceuticals, Inc. (OTCQB: INNV), a specialty pharmaceutical company commercializing, licensing and developing safe and effective consumer health products, today announced that the companies have signed a definitive merger agreemen

At the 2019 ASTRO Annual Meeting beginning September 15th in Chicago, Sun Nuclear Corporation will present novel advancements in radiation oncology Quality Management.

Navitor Pharmaceuticals, Inc., the leader in the discovery and development of mTORC1-targeted therapeutics designed to help patients live longer and healthier lives, announced today the successful completion of three Phase 1 studies for NV-5138, which is in development for patients with depression.

The Board of Directors has appointed Mrs. Elcin Barker Ergun as CEO of Menarini Group.

Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative hematology solutions to drive better patient outcomes, today announced the appointment of Stewart W. Strong as President, Global Hospital, effective Sept. 16, 2019